Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

403
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
403
Random Error01:04

Random Error

9.1K
Random or indeterminate errors originate from various uncontrollable variables, such as variations in environmental conditions, instrument imperfections, or the inherent variability of the phenomena being measured. Usually, these errors cannot be predicted, estimated, or characterized because their direction and magnitude often vary in magnitude and direction even during consecutive measurements. As a result, they are difficult to eliminate. However, the aggregate effect of these errors can be...
9.1K
Random Variables01:09

Random Variables

17.6K
A random variable is a single numerical value that indicates the outcome of a procedure. The concept of random variables is fundamental to the probability theory and was introduced by a Russian mathematician, Pafnuty Chebyshev, in the mid-nineteenth century.
Uppercase letters such as X or Y denote a random variable. Lowercase letters like x or y denote the value of a random variable. If X is a random variable, then X is written in words, and x is given as a number.
For example, let X = the...
17.6K
Randomized Experiments01:13

Randomized Experiments

8.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of three different hpv self-sampling tools - a subanalysis of the prospective, randomized hannover self-collection study.

Archives of gynecology and obstetrics·2026
Same author

DIGIT-HF: Results From the Win Ratio Analyses.

Circulation. Heart failure·2026
Same author

Digitoxin in heart failure with reduced ejection fraction according to atrial fibrillation status: the DIGIT-HF trial.

European heart journal·2026
Same author

A Statistical Concept for Conditional Marketing Authorisation Based on the Intermediate and Final Outcomes of a Single Confirmatory Randomised Clinical Trial.

Pharmaceutical statistics·2026
Same author

Menopausal Hormone Labels Should Rely on Evidence, Not Opinion.

JAMA·2026
Same author

Subgroups and Special Populations in Heart Failure Clinical Trials: Insights From the HFC-ARC Expert Consensus Panel.

JACC. Heart failure·2026

Related Experiment Video

Updated: Jan 23, 2026

Assessment of Mouse Judgment Bias through an Olfactory Digging Task
12:10

Assessment of Mouse Judgment Bias through an Olfactory Digging Task

Published on: March 4, 2022

3.1K

Digoxin-mortality: randomized vs. observational comparison in the DIG trial.

Lukas Aguirre Dávila1, Kristina Weber1, Udo Bavendiek2

  • 1Institute for Biostatistics, Hannover Medical School, Carl-Neuberg Str. 1, 30625 Hannover, Germany.

European Heart Journal
|June 19, 2019
PubMed
Summary

Digoxin treatment in heart failure patients showed no mortality benefit in the DIG trial. Observational studies suggest increased risk, highlighting limitations in bias control for non-randomized comparisons.

Keywords:
Cardiac glycosidesDigoxinHeart failureMortalityPrescription biasRandomization

More Related Videos

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.5K
Reliable Method for Assessing Seed Germination, Dormancy, and Mortality under Field Conditions
07:03

Reliable Method for Assessing Seed Germination, Dormancy, and Mortality under Field Conditions

Published on: November 6, 2016

11.0K

Related Experiment Videos

Last Updated: Jan 23, 2026

Assessment of Mouse Judgment Bias through an Olfactory Digging Task
12:10

Assessment of Mouse Judgment Bias through an Olfactory Digging Task

Published on: March 4, 2022

3.1K
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.5K
Reliable Method for Assessing Seed Germination, Dormancy, and Mortality under Field Conditions
07:03

Reliable Method for Assessing Seed Germination, Dormancy, and Mortality under Field Conditions

Published on: November 6, 2016

11.0K

Area of Science:

  • Cardiology
  • Clinical Trials
  • Observational Studies

Background:

  • The Digitalis Investigation Group (DIG) trial is the primary randomized study on digoxin for heart failure, showing neutral mortality but reduced hospitalizations.
  • Recent observational studies suggest digoxin may increase mortality, contrasting with DIG trial findings.
  • This study re-examines DIG trial data to assess bias in observational comparisons.

Purpose of the Study:

  • To analyze the Digitalis Investigation Group (DIG) trial data further.
  • To demonstrate the challenges in controlling bias in observational studies of digoxin treatment.
  • To compare randomized versus observational analyses of digoxin's effects on mortality and heart failure hospitalizations.

Main Methods:

  • Analysis of data from the Digitalis Investigation Group (DIG) trial, involving 6800 heart failure patients.
  • Comparison of the main randomized trial results with observational analyses of pre-randomization digoxin use.
  • Statistical adjustments were applied to observational comparisons to account for baseline differences.

Main Results:

  • Observational analysis showed significantly higher mortality (HR 1.22) and heart failure hospitalizations (HR 1.47) in patients pre-treated with digoxin, even after adjustments.
  • These increased risks persisted even for pre-treated patients randomized to placebo (HR 1.24 for mortality).
  • These findings contradict the neutral mortality effect and reduced hospitalization rates observed in the randomized DIG trial comparison.

Conclusions:

  • Digoxin prescription is an indicator of disease severity and poor prognosis, difficult to fully adjust for in analyses.
  • Observational studies using administrative data or registries are unlikely to yield more reliable estimates of cardiac glycoside effects than randomized trials.
  • The DIG trial's randomized approach remains the most reliable method for assessing digoxin's true impact on heart failure outcomes.